Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study

European Journal of Nutrition
Khalid IqbalHeiner Boeing

Abstract

The aim of the study was to investigate the association between the previously identified Gaussian graphical models' (GGM) food intake networks and risk of major chronic diseases as well as intermediate biomarkers in the European Prospective Investigation into Cancer and nutrition (EPIC)-Potsdam cohort. In this cohort analysis of 10,880 men and 13,340 women, adherence to the previously identified sex-specific GGM networks as well as principal component analysis identified patterns was investigated in relation to risk of major chronic diseases, using Cox-proportional hazard models. Associations of the patterns with intermediate biomarkers were cross-sectionally analyzed using multiple linear regressions. Results showed that higher adherence to the GGM Western-type pattern was associated with increased risk (Hazard Ratio: 1.55; 95% CI 1.13-2.15; P trend = 0.004) of type 2 diabetes (T2D) in women, whereas adherence to a high-fat dairy (HFD) pattern was associated with lower risk of T2D both in men (0.69; 95% CI 0.54-0.89; P trend < 0.001) and women (0.71; 95% CI: 0.53, 0.96; P trend = 0.09). Among PCA patterns, HFD pattern was associated with lower risk of T2D (0.74; 95% CI 0.58-0.95; P trend < 0.001) in men and bread and sausage ...Continue Reading

References

Apr 1, 1997·The American Journal of Clinical Nutrition·W C WillettL H Kushi
Dec 11, 1999·Annals of Nutrition & Metabolism·H BoeingM M Bergmann
Jan 16, 2002·Current Opinion in Lipidology·Frank B Hu
Feb 6, 2002·Annals of Internal Medicine·Rob M van DamFrank B Hu
Mar 12, 2003·The British Journal of Nutrition·Matthias B SchulzeHeiner Boeing
Nov 10, 2004·Archives of Internal Medicine·Teresa T FungFrank B Hu
Jan 27, 2005·American Journal of Epidemiology·Jukka MontonenAntti Reunanen
Feb 14, 2006·The American Journal of Clinical Nutrition·Thomas L HaltonFrank B Hu
Jul 18, 2008·Diabetes·Norbert StefanMatthias B Schulze
Oct 14, 2009·Diabetologia·K KiriiUNKNOWN Japan Public Health Center-based Prospective Study Group
Jan 19, 2011·American Journal of Epidemiology·Michelle A MendezCarlos A González
May 12, 2011·European Journal of Clinical Nutrition·X TongL-Q Qin
Jan 29, 2013·Current Diabetes Reports·Edith J M FeskensGeertruida J van Woudenbergh
Aug 16, 2013·The American Journal of Clinical Nutrition·Dagfinn AuneLars J Vatten
Jul 9, 2014·Journal of the Academy of Nutrition and Dietetics·Claire T McEvoyMichelle C McKinley
Apr 3, 2015·The American Journal of Clinical Nutrition·Ulrika EricsonMarju Orho-Melander
Jan 29, 2016·The Journal of Nutrition·Khalid IqbalHeiner Boeing
Feb 26, 2016·The British Journal of Nutrition·Simone J P M EussenPieter C Dagnelie
Apr 12, 2017·European Journal of Epidemiology·Lukas SchwingshacklHeiner Boeing
Apr 21, 2017·The Journal of Nutrition·Franziska JannaschMatthias B Schulze
Jul 27, 2017·European Journal of Clinical Nutrition·K IqbalH Boeing

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.